Evaluation of two different classes of compounds (STAT3 inhibitors and serms) for the prevention of urinary bladder cancer.
Active Awarded Last action
- Contract number
- 75N91020F00005
- Awardee
-
University Of Oklahoma UEI GY8NMUZQXVS7 Part of University Of Oklahoma
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $909,994
Award facts
- Opportunity
- Contract value 100% obligated
- $909,993.85 Current and potential, with all options
- Completion date 99% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- PSC
- AN91 R&D- Medical: Other (Basic Research)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Oklahoma City, OK 73104, USA
- Legislative mandates
-
- Walsh-Healey Public Contracts Act FAR subpart 22.6
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Funding Only Action | -$370 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $244,086 | |
| Original award | $666,278 |
About this award
The University of Oklahoma Health Sciences Center (OUHSC) was awarded a $909,993.85 firm fixed-price delivery order by the National Cancer Institute on September 21, 2020, for the evaluation of two different classes of compounds—STAT3 inhibitors and selective estrogen receptor modulators (SERMs)—for the prevention of urinary bladder cancer. This delivery order is issued under the PREVENT Cancer Preclinical Drug Development Program, an expansive National Cancer Institute Indefinite Delivery/Indefinite Quantity (IDIQ) contract valued at approximately $149,995,000 that supports preclinical drug development research including evaluation of efficacy and pharmacodynamic biomarkers for potential cancer preventive agents. The work is to be performed at OUHSC's location in Oklahoma City, Oklahoma, with an ultimate completion date of November 1, 2026. No set-aside designation was used in this award, indicating open competition.
This delivery order supports the National Cancer Institute's strategic focus on cancer prevention research by leveraging OUHSC's established capabilities in biomedical research and cancer-focused investigation. As a comprehensive academic medical institution and significant federal research partner, OUHSC has demonstrated substantial experience with the PREVENT program, having previously secured multiple delivery orders under the same master IDIQ contract, including projects focused on mitochondrial-targeted honokiol for lung adenocarcinoma prevention and multivalent mRNA vaccine development for triple-negative breast cancer. The University of Oklahoma serves as the parent entity, operating through its Office of Research Services to facilitate the institution's extensive federal research portfolio.
Quick answers
Who was awarded contract 75N91020F00005?
75N91020F00005 was awarded to University Of Oklahoma by National Cancer Institute (National Institutes of Health) on September 21, 2020.
How much is contract 75N91020F00005 worth?
The government has obligated $909,994 on 75N91020F00005.
Is contract 75N91020F00005 an order under another contract?
Yes. 75N91020F00005 is a delivery order under 75N91019D00020, an indefinite delivery contract, on PREVENT Preclinical Drug Development Program (PREVENT).
Was contract 75N91020F00005 competed?
The extent of competition for 75N91020F00005 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award